Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

29.83 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline
Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks
Via AB Newswire
Four Undervalued Healthcare Stocks for 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc. 
Via MarketBeat
Exposures COVID-19
A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca
Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
From Pfizer Inc.
Via Business Wire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
The Year of the Tripledemic
COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which... 
Via TheNewswire.com
Topics Death
Exposures COVID-19 Death Product Safety
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
From Pfizer Inc.
Via Business Wire
Big Health Care Stocks to Watch in the New Year
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now. 
Via MarketBeat
U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
From Pfizer Inc.
Via Business Wire
Why Did Immutep Ltd Stock Soar Recently?
Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate. 
Via MarketBeat
Topics Initial Public Offering
Exposures Product Safety Securities Market
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
Vaccines & Vaccination Market May Set Epic Growth Story : Pfizer, Merck, Johnson & Johnson
Stay up-to-date with Vaccines & Vaccination Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
From Pfizer Inc.
Via Business Wire
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum 
Via MarketBeat
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
From LianBio; Pfizer Inc.
Via GlobeNewswire
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... 
Via TheNewswire.com
Topics Death
Exposures Death
NYSE:PFE Investor Notice: Investigation over Breaches of Fiduciary Duties at Pfizer Inc.
San Diego, CA -- (SBWIRE) -- 12/13/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Pfizer Inc. 
Via SBWire
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
From Pfizer Inc.
Via Business Wire
MarketBeat: Week in Review 12/05 – 12/09
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week. 
Via MarketBeat
Topics Economy Electric Vehicles Supply Chain
Exposures Electric Vehicles Interest Rates Supply Chain
Pfizer Declares First-Quarter 2023 Dividend
From Pfizer Inc.
Via Business Wire
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months. 
Via MarketBeat
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
From Pfizer Inc.
Via Business Wire
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled with reports. In the winter issue of the Journal of... 
Via Newswire.com
Exposures COVID-19
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults
From Pfizer Inc.
Via Business Wire
Nanomedicine Market Size & Share Report 2022 : Reach at US$ 238.4 Bn and Grow at Healthy CAGR 10.1% During Forecast Period 2022-2028
"Emerging innovative technologies for drug delivery, the benefits of nanomedicine in various healthcare applications, and the increase in the demand for safe and inexpensive treatments drive the growth... 
Via SBWire
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
From Pfizer Inc.
Via Business Wire
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
From Pfizer Inc.
Via Business Wire
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
From Roivant Sciences
Via GlobeNewswire
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.